figure 8:
a) cumulative in vitro brimonidine tartrate release from bt-loaded microparticles embedded in the original and new formulations of hydrogel. b) daily release of brimonidine tartrate compared to the minimum and maximum levels of topical bt absorbed into the anterior chamber.